Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Annales De Cardiologie Et D'Angeiologie
|
February 1, 2017
[Costs of healthcare resource consumption after a myocardial infarction in France: An estimate from a medicoadministrative database (GSB)]
F Philippe, P Blin, S Bouée, et al.
Clinical Pharmacology and Therapeutics
|
September 24, 2010
When patients report diseases that prescribers seem unaware of: discordance between patient and physician reporting of risk-related previous history in NSAID users from the CADEUS study
A Fourrier-Réglat, L Lacoin, A Pariente, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris
|
January 1, 1996
[Apropos of 2 cases of mucocele with major ophthalmologic complications treated by endoscopic endonasal surgery]
A Hazan, P Blin, C Peytral, et al.
Presse Medicale (Paris, France : 1983)
|
May 8, 2003
[Infections by Candida sp. in intensive care. Survey of French practices]
R Gauzit, Y Cohen, H Dupont, et al.
Journal of Viral Hepatitis
|
April 14, 2006
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine
F Zoulim, T Poynard, F Degos, et al.
Diabetologia
|
January 7, 2012
Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
P Blin, R Lassalle, C Dureau-Pournin, et al.
Pharmacoepidemiology and Drug Safety
|
March 14, 2007
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study
F Depont, A Fourrier, Y Merlière, et al.
European Journal of Neurology
|
November 13, 2014
Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database
P Blin, C Dureau-Pournin, A Foubert-Samier, et al.
Diabetes Care
|
June 6, 1998
Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps
V Melki, E Renard, V Lassmann-Vague, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
The 3.5-Year Mortality Impact Of Drugs In Secondary Prevention Of Myocardial Infarction In Real-Life (Interim Analysis Of The Eole Cohort)
C Droz, C Dureau, D Thomas, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Annales De Cardiologie Et D'Angeiologie
|
February 1, 2017
[Costs of healthcare resource consumption after a myocardial infarction in France: An estimate from a medicoadministrative database (GSB)]
F Philippe, P Blin, S Bouée, et al.
Clinical Pharmacology and Therapeutics
|
September 24, 2010
When patients report diseases that prescribers seem unaware of: discordance between patient and physician reporting of risk-related previous history in NSAID users from the CADEUS study
A Fourrier-Réglat, L Lacoin, A Pariente, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris
|
January 1, 1996
[Apropos of 2 cases of mucocele with major ophthalmologic complications treated by endoscopic endonasal surgery]
A Hazan, P Blin, C Peytral, et al.
Presse Medicale (Paris, France : 1983)
|
May 8, 2003
[Infections by Candida sp. in intensive care. Survey of French practices]
R Gauzit, Y Cohen, H Dupont, et al.
Journal of Viral Hepatitis
|
April 14, 2006
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine
F Zoulim, T Poynard, F Degos, et al.
Diabetologia
|
January 7, 2012
Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
P Blin, R Lassalle, C Dureau-Pournin, et al.
Pharmacoepidemiology and Drug Safety
|
March 14, 2007
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study
F Depont, A Fourrier, Y Merlière, et al.
European Journal of Neurology
|
November 13, 2014
Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database
P Blin, C Dureau-Pournin, A Foubert-Samier, et al.
Diabetes Care
|
June 6, 1998
Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps
V Melki, E Renard, V Lassmann-Vague, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
The 3.5-Year Mortality Impact Of Drugs In Secondary Prevention Of Myocardial Infarction In Real-Life (Interim Analysis Of The Eole Cohort)
C Droz, C Dureau, D Thomas, et al.
Page
of 5